Description

The US pharmaceutical landscape is in the midst of impactful shifts. A series of ambitious, aggressive, and often interconnected federal policy changes--from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches--is creating a new reality for industry leaders, innovators, and strategists. In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.

Key Features

-Understand the Interconnectedness of U.S. Federal Policies.

-Analyze the Strategic Impacts of Key Legislation and Executive Actions.

-Evaluate Challenges and Opportunities in a Dynamic Regulatory Environment.

-Analyze the Interplay of U.S. Federal Actions and Industry Operations.

-Formulate Adaptive Strategies for Industry Resilience.